Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Venetoclax
Related studies linked through entity extraction aliases.
Venetoclax After TKI to Target Persisting Stem Cells in CML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Olverembatinib Combined With Reduced-Intensity Chemotherapy and Venetoclax for de Novo Ph+ ALL
- Status
- COMPLETED
- Phase
- PHASE2
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH
- Status
- UNKNOWN
- Phase
- PHASE1
Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
- Status
- RECRUITING
- Phase
- PHASE2
Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2